Medical Properties Trust, Inc. (NYSE:MPW) Shares Sold by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC reduced its position in shares of Medical Properties Trust, Inc. (NYSE:MPW) by 7.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 34,509 shares of the real estate investment trust’s stock after selling 2,822 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Medical Properties Trust were worth $202,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. grew its stake in Medical Properties Trust by 8.2% during the 1st quarter. Vanguard Group Inc. now owns 93,058,174 shares of the real estate investment trust’s stock valued at $437,373,000 after purchasing an additional 7,084,981 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Medical Properties Trust by 4.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 8,622,683 shares of the real estate investment trust’s stock valued at $37,168,000 after buying an additional 328,184 shares during the last quarter. Bank of New York Mellon Corp grew its position in shares of Medical Properties Trust by 22.6% during the second quarter. Bank of New York Mellon Corp now owns 6,908,362 shares of the real estate investment trust’s stock worth $29,775,000 after buying an additional 1,274,481 shares in the last quarter. Wilsey Asset Management Inc. increased its stake in shares of Medical Properties Trust by 27.2% in the second quarter. Wilsey Asset Management Inc. now owns 4,376,180 shares of the real estate investment trust’s stock worth $18,861,000 after buying an additional 936,631 shares during the last quarter. Finally, Goldentree Asset Management LP acquired a new stake in Medical Properties Trust in the first quarter valued at $15,966,000. 71.79% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

MPW has been the subject of several recent analyst reports. Colliers Securities raised shares of Medical Properties Trust from a “neutral” rating to a “buy” rating and set a $6.50 price objective for the company in a report on Friday, September 13th. Truist Financial lifted their price target on Medical Properties Trust from $5.00 to $6.00 and gave the stock a “hold” rating in a research note on Friday, September 13th. Finally, Wolfe Research raised Medical Properties Trust to a “hold” rating in a report on Monday, September 23rd. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $5.50.

Medical Properties Trust Price Performance

MPW opened at $4.36 on Wednesday. The company has a quick ratio of 2.93, a current ratio of 2.38 and a debt-to-equity ratio of 1.69. The company’s 50-day moving average price is $5.17 and its 200 day moving average price is $4.92. Medical Properties Trust, Inc. has a fifty-two week low of $2.92 and a fifty-two week high of $6.55. The firm has a market cap of $2.61 billion, a price-to-earnings ratio of -1.03, a price-to-earnings-growth ratio of 0.72 and a beta of 1.32.

Medical Properties Trust Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, October 10th. Investors of record on Monday, September 9th were issued a $0.08 dividend. This represents a $0.32 annualized dividend and a dividend yield of 7.35%. The ex-dividend date of this dividend was Monday, September 9th. Medical Properties Trust’s dividend payout ratio (DPR) is -7.58%.

Insider Activity at Medical Properties Trust

In other Medical Properties Trust news, Director C Reynolds Thompson III sold 20,530 shares of the firm’s stock in a transaction on Tuesday, August 27th. The stock was sold at an average price of $4.38, for a total value of $89,921.40. Following the sale, the director now directly owns 54,637 shares in the company, valued at approximately $239,310.06. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In related news, Director Michael G. Stewart sold 32,780 shares of the stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $5.46, for a total value of $178,978.80. Following the completion of the transaction, the director now directly owns 221,245 shares of the company’s stock, valued at $1,207,997.70. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director C Reynolds Thompson III sold 20,530 shares of Medical Properties Trust stock in a transaction on Tuesday, August 27th. The shares were sold at an average price of $4.38, for a total value of $89,921.40. Following the sale, the director now directly owns 54,637 shares in the company, valued at $239,310.06. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 63,335 shares of company stock worth $318,825 in the last 90 days. 1.53% of the stock is currently owned by company insiders.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.